IGC Pharma, Inc. (IGC)
NYSEAMERICAN: IGC · Real-Time Price · USD
0.2818
-0.0088 (-3.03%)
Mar 12, 2026, 2:59 PM EDT - Market open

IGC Pharma Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
272327184886
Market Cap Growth
18.43%-13.59%48.04%-62.80%-43.41%344.34%
Enterprise Value
26.5422.7925.715.0238.4771.97
Last Close Price
0.280.280.400.340.951.79
PE Ratio
--3.17-1.82-1.54-3.16-8.52
Forward PE
-4.354.354.354.354.35
PEG Ratio
-2.262.262.262.262.26
PS Ratio
24.8918.1419.8319.78122.0395.33
PB Ratio
3.303.643.641.212.032.61
P/TBV Ratio
2.313.443.221.201.992.29
P/FCF Ratio
--4.70-5.00-2.45-6.29-6.98
P/OCF Ratio
--4.81-5.13-2.56-6.49-7.93
EV/Sales Ratio
24.0017.9319.1116.4896.9080.14
EV/EBITDA Ratio
--3.34-2.81-1.38-2.60-8.73
EV/EBIT Ratio
--3.06-2.62-1.30-2.49-8.25
EV/FCF Ratio
--4.64-4.82-2.04-5.00-5.87
Debt / Equity Ratio
0.020.020.030.020.020.03
Debt / EBITDA Ratio
-0.02-0.02-0.02-0.03-0.03-0.12
Debt / FCF Ratio
-0.02-0.03-0.04-0.05-0.06-0.08
Net Debt / Equity Ratio
-0.10-0.04-0.13-0.20-0.42-0.42
Net Debt / EBITDA Ratio
0.130.040.110.280.681.65
Net Debt / FCF Ratio
0.180.050.180.411.301.11
Asset Turnover
0.120.140.100.040.010.03
Inventory Turnover
0.540.450.290.150.040.16
Quick Ratio
0.770.180.531.824.346.25
Current Ratio
1.321.281.583.416.199.93
Return on Equity (ROE)
-89.83%-104.33%-116.95%-59.30%-52.97%-29.70%
Return on Assets (ROA)
-86.01%-79.85%-72.36%-52.58%-49.21%-26.90%
Return on Invested Capital (ROIC)
-124.05%-119.62%-107.12%-89.48%-93.20%-51.43%
Return on Capital Employed (ROCE)
-110.50%-105.98%-85.79%-58.33%-53.30%-28.82%
Earnings Yield
-23.42%-31.58%-55.00%-64.80%-31.62%-11.73%
FCF Yield
-20.44%-21.29%-20.01%-40.83%-15.89%-14.33%
Buyback Yield / Dilution
-13.34%-19.32%-13.22%-0.57%-8.56%-16.54%
Updated Nov 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q